Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M276,881Revenue $M74,331Net Margin (%)21.6Z-Score5.2
Enterprise Value $M262,552EPS $5.7Operating Margin %28.1F-Score7
P/E(ttm))17.6Cash Flow Per Share $6.2Pre-tax Margin (%)28.2Higher ROA y-yY
Price/Book4.010-y EBITDA Growth Rate %4.3Quick Ratio2.0Cash flow > EarningsY
Price/Sales3.85-y EBITDA Growth Rate %3.5Current Ratio2.4Lower Leverage y-yN
Price/Cash Flow11.3y-y EBITDA Growth Rate %24.9ROA % (ttm)14.4Higher Current Ratio y-yY
Dividend Yield %2.8Insider Buy (3m)0ROE % (ttm)25.5Less Shares Outstanding y-yY
Payout Ratio %48.0Shares Outstanding M2,780ROI % (ttm)15.4Gross Margin Increase y-yY

Gurus Latest Trades with JNJ

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
JNJYacktman Focused Fund 2015-03-31 Reduce-0.11%$98.32 - $106.39
($101.69)
$ 99.58-2%Reduce -3.23%3,000,000
JNJJoel Greenblatt 2014-12-31 Add0.66%$96.78 - $109.07
($105.43)
$ 99.58-6%Add 5420.84%790,529
JNJRobert Olstein 2014-12-31 Reduce-0.17%$96.78 - $109.07
($105.37)
$ 99.58-6%Reduce -14.46%71,000
JNJJohn Rogers 2014-12-31 Add0.11%$96.78 - $109.07
($105.37)
$ 99.58-6%Add 17.80%632,132
JNJHOTCHKIS & WILEY 2014-12-31 Sold Out $96.78 - $109.07
($105.37)
$ 99.58-6%Sold Out0
JNJHOTCHKIS & WILEY 2014-09-30 Reduce-0.53%$99.82 - $108.64
($103.64)
$ 99.58-4%Reduce -99.80%2,862
JNJJames Barrow 2014-09-30 Reduce-0.24%$99.82 - $108.64
($103.64)
$ 99.58-4%Reduce -10.05%15,350,650
JNJYacktman Focused Fund 2014-09-30 Reduce-0.21%$99.82 - $108.64
($103.64)
$ 99.58-4%Reduce -6.06%3,100,000
JNJDonald Yacktman 2014-09-30 Reduce-0.17%$99.82 - $108.64
($103.64)
$ 99.58-4%Reduce -4.36%8,651,258
JNJYacktman Fund 2014-09-30 Reduce-0.13%$99.82 - $108.64
($103.64)
$ 99.58-4%Reduce -3.70%3,900,000
JNJGeorge Soros 2014-09-30 Sold Out -0.04%$99.82 - $108.64
($103.64)
$ 99.58-4%Sold Out0
JNJJoel Greenblatt 2014-09-30 Buy 0.02%$99.82 - $108.64
($103.64)
$ 99.58-4%New holding14,319
JNJDodge & Cox 2014-09-30 Add$99.82 - $108.64
($103.64)
$ 99.58-4%Add 21.93%47,095
JNJHOTCHKIS & WILEY 2014-06-30 Reduce-0.89%$96.54 - $105.76
($101.02)
$ 99.58-1%Reduce -63.73%1,426,614
JNJYacktman Focused Fund 2014-06-30 Reduce-0.51%$96.54 - $105.76
($101.02)
$ 99.58-1%Reduce -13.16%3,300,000
JNJRobert Olstein 2014-06-30 Reduce-0.31%$96.54 - $105.76
($101.02)
$ 99.58-1%Reduce -20.91%87,000
JNJDonald Yacktman 2014-06-30 Reduce-0.21%$96.54 - $105.76
($101.02)
$ 99.58-1%Reduce -5.50%9,045,902
JNJJohn Rogers 2014-06-30 Add0.2%$96.54 - $105.76
($101.02)
$ 99.58-1%Add 42.46%522,727
JNJRichard Pzena 2014-06-30 Add0.17%$96.54 - $105.76
($101.02)
$ 99.58-1%Add 33.12%1,155,666
JNJTweedy Browne 2014-06-30 Reduce-0.17%$96.54 - $105.76
($101.02)
$ 99.58-1%Reduce -1.71%4,196,224
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

JNJ is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


JNJ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Fasolo PeterVP, Global Human Resources 2015-03-05Sell115,307$102.4-1.81view
COSGROVE STEPHEN JCorporate Controller 2014-11-05Sell2,490$108.55-7.37view
Ullmann Michael HVP, General Counsel 2014-10-31Sell17,350$107.43-6.4view
CULLEN JAMESDirector 2014-09-10Sell2,446$104.12-3.43view
Caruso Dominic JVP, Finance; CFO 2014-08-21Sell30,000$104.3-3.6view
COSGROVE STEPHEN JCorporate Controller 2014-05-05Sell22,000$100.050.5view
Fasolo PeterVP, Global Human Resources 2014-03-14Sell6,824$93.157.94view
COSGROVE STEPHEN JCorporate Controller 2013-08-14Sell17,200$91.3910.02view
Ullmann Michael HVP, General Counsel 2013-08-05Sell16,140$93.687.33view
Stoffels PaulusChief Scientific Officer 2013-07-25Sell45,440$92.48.82view

Press Releases about JNJ :

    Quarterly/Annual Reports about JNJ:

    News about JNJ:

    Articles On GuruFocus.com
    Process Vs Outcome, Revisited Apr 07 2015 
    Johnson and Johnson: Well Positioned for Long-Term Growth Apr 06 2015 
    iRA Apr 06 2015 
    Google And Johnson & Johnson Likely To Collaborate For Developing A Break Through Technology Mar 31 2015 
    Google Set To Bring In A Difference In The World Of Surgery Mar 30 2015 
    Johnson & Johnson A Good Pick For Dividend Stock Mar 27 2015 
    What Are The Intrinsic Factors Contributing To Pfizer’s Stock Movement? Mar 27 2015 
    Biogen And Idec To Part Ways After Inventing Alzheimer's Drug Mar 27 2015 
    These 10 Stocks Swim In Cash Mar 17 2015 
    7 Stocks With A Strong Cash To Dividend Coverage Mar 17 2015 


    More From Other Websites
    IBM Pulls Apple, J&J Into Watson Health Data Alliance Apr 13 2015
    Are Sales for This J&J Drug About to Stall? Apr 13 2015
    IBM Positions Itself as Large Broker of Health Data Apr 13 2015
    IBM strikes digital health deal with Apple, Medtronic and J&J Apr 13 2015
    US STOCKS-Wall St declines as worries about earnings deepen Apr 13 2015
    IBM launches new health unit, teams up with Apple, J&J, Medtronic Apr 13 2015
    IBM launches new health unit, teams up with Apple, J&J, Medtronic Apr 13 2015
    IBM Announces Deals With Apple, Johnson And Johnson, And Medtronic In Bid To Transform Health Care Apr 13 2015
    IBM launches new health unit, teams up with Apple, J&J, Medtronic Apr 13 2015
    IBM Adds Apple, Others to Watson Partnership, Unveils Watson Health Cloud Apr 13 2015
    IBM Joins With Apple, J&J to Analyze Health Data in the Cloud Apr 13 2015
    How the Dow Jones industrial average fared Monday Apr 13 2015
    US STOCKS-Wall St ends down as earnings worries deepen Apr 13 2015
    US stock market slips in light trading Apr 13 2015
    US stock market slips in light trading Apr 13 2015
    Former Execs Charged With Securities Fraud at Device Maker Bought by J&J Apr 13 2015
    The 4 Stocks That Sank the Dow on Monday Apr 13 2015
    What to watch for in Johnson & Johnson earnings Apr 13 2015
    What to Expect When Johnson & Johnson (JNJ) Reports First-Quarter Earnings Tomorrow Apr 13 2015
    US STOCKS-Dow, S&P 500 edge lower as earnings worries deepen Apr 13 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    Gurufocus
    ReplyGurufocus - 1 year ago
    test
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK